510(k) Report

510(k) · Cleared

Cleared

Autoldl Cholesterol Reagent Set and Autoldl Cholesterol Calibrator

K981978510(k) TraditionalCleared Jul 22, 199847-day reviewClass I21 CFR 862.1475

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pointe Scientific, Inc., · MRR System, Test, Low Density, Lipoprotein

Cleared on Jul 22, 1998 after a 47-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Jul 22, 1998
Review
47 days
Class
Class I
Product code
MRR
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K981978Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MRR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MRR device

  1. #1 K241800 Atellica® CH HDL Cholesterol (HDLC)& Atellica®…score 8.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MRR devices

MRR System, Test, Low Density, Lipoprotein: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MRR

1in 2024

2008: 12009: 22017: 12023: 12024: 1
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MRR

Too few MRR 510(k)s in any year since 2007 to give a median.

Recalls per year · MRR

1in 2025

2008: 22018: 12025: 1
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MRR

1in 2024

2011: 32017: 32018: 22020: 12021: 12022: 12023: 12024: 1
2007high 3 (2011) · low 0 (2007)2025

MAUDE reports naming product code MRR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—20
20092—00
20100—00
20110—03
20120—00
20130—00
20140—00
20150—00
20160—00
20171—03
20180—12
20190—00
20200—01
20210—01
20220—01
20231—01
20241—01
20250—10
20260—0—

What is it indicated for?

This product is to be used in a diagnostic laboratory setting, by qualified laboratory technologists, for the quantitative determination of low density lipoprotein (LDL) cholesterol in serum or plasma. LDL cholesterol is a key factor in the pathogenesis of atherosclerosis and coronary artery disease. An increase in LDL cholestrerol can occur with an associated risk for coronary artery disease even within a normal total cholesterol concentration. This reagent set is intended for in vitro diagnostic use only.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K981978: Autoldl Cholesterol Reagent Set and Autoldl Cholesterol Calibrator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K981978

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026